Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yadgir Simon, Johnson Catherine Owens, Aboyans Victor, Adebayo Oladimeji M, Adedoyin Rufus Adesoji, Afarideh Mohsen, Alahdab Fares, Alashi Alaa, Alipour Vahid, Arabloo Jalal, Azari Samad, Barthelemy Celine M, Benziger Catherine P, Berman Adam E, Bijani Ali, Carrero Juan J, Carvalho Félix, Daryani Ahmad, Durães Andre R, Esteghamati Alireza, Farid Talha A, Farzadfar Farshad, Fernandes Eduarda, Filip Irina, Gad Mohamed M, Hamidi Samer, Hay Simon I, Ilesanmi Olayinka Stephen, Naghibi Irvani Seyed Sina, Jürisson Mikk, Kasaeian Amir, Kengne Andre Pascal, Khan Abdur Rahman, Kisa Adnan, Kisa Sezer, Kolte Dhaval, Manafi Navid, Manafi Amir, Mensah George A, Mirrakhimov Erkin M, Mohammad Yousef, Mokdad Ali H, Negoi Ruxandra Irina, Thi Nguyen Huong Lan, Nguyen Trang Huyen, Nixon Molly R, Otto Catherine M, Patel Shanti, Pilgrim Thomas, Radfar Amir, Rawaf David Laith, Rawaf Salman, Rawasia Wasiq Faraz, Rezapour Aziz, Roever Leonardo, Saad Anas M, Saadatagah Seyedmohammad, Senthilkumaran Subramanian, Sliwa Karen, Tesfay Berhe Etsay, Tran Bach Xuan, Ullah Irfan, Vaduganathan Muthiah, Vasankari Tommi Juhani, Wolfe Charles D A, Yonemoto Naohiro, Roth Gregory A, Global Burden of Disease Study 2017 Nonrheumatic Valve Disease Collaborators
Аннотация
METHODS: Vital registration data, epidemiologic survey data, and administrative hospital data were used to estimate disease burden using the Global Burden of Disease Study modeling framework, which ensures comparability across locations. Geospatial statistical methods were used to estimate disease for all countries, because data on nonrheumatic valvular diseases are extremely limited for some regions of the world, such as Sub-Saharan Africa and South Asia. Results accounted for estimated level of disease severity as well as the estimated availability of valve repair or replacement procedures. DALYs and other measures of health-related burden were generated for both sexes and each 5-year age group, location, and year from 1990 to 2017.
RESULTS: Globally, CAVD and degenerative mitral valve disease caused 102 700 (95% uncertainty interval [UI], 82 700-107 900) and 35 700 (95% UI, 30 500-42 500) deaths, and 12.6 million (95% UI, 11.4 million-13.8 million) and 18.1 million (95% UI, 17.6 million-18.6 million) prevalent cases existed in 2017, respectively. A total of 2.5 million (95% UI, 2.3 million-2.8 million) DALYs were estimated as caused by nonrheumatic valvular diseases globally, representing 0.10% (95% UI, 0.09%-0.11%) of total lost health from all diseases in 2017. The number of DALYs increased for CAVD and degenerative mitral valve disease between 1990 and 2017 by 101% (95% UI, 79%-117%) and 35% (95% UI, 23%-47%), respectively. There is significant geographic variation in the prevalence, mortality rate, and overall burden of these diseases, with highest age-standardized DALY rates of CAVD estimated for high-income countries.
CONCLUSIONS: These global and national estimates demonstrate that CAVD and degenerative mitral valve disease are important causes of disease burden among older adults. Efforts to clarify modifiable risk factors and improve access to valve interventions are necessary if progress is to be made toward reducing, and eventually eliminating, the burden of these highly treatable diseases.